Stifel Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-919
| Closed | -$5.63K | – | 3378 |
|
|
2023
Q4 | $5.63K | Sell |
919
-108
| -11% | -$661 | ﹤0.01% | 3302 |
|
|
2023
Q3 | $4.8K | Sell |
1,027
-59
| -5% | -$276 | ﹤0.01% | 3269 |
|
|
2023
Q2 | $5.82K | Sell |
1,086
-53
| -5% | -$284 | ﹤0.01% | 3312 |
|
|
2023
Q1 | $11.2K | Sell |
1,139
-38
| -3% | -$374 | ﹤0.01% | 3308 |
|
|
2022
Q4 | $22K | Sell |
1,177
-1,542
| -57% | -$28.9K | ﹤0.01% | 3239 |
|
|
2022
Q3 | $56K | Buy |
2,719
+161
| +6% | +$3.32K | ﹤0.01% | 3175 |
|
|
2022
Q2 | $53K | Buy |
2,558
+25
| +1% | +$518 | ﹤0.01% | 3224 |
|
|
2022
Q1 | $109K | Hold |
2,533
| – | – | ﹤0.01% | 3249 |
|
|
2021
Q4 | $151K | Sell |
2,533
-458
| -15% | -$27.3K | ﹤0.01% | 3200 |
|
|
2021
Q3 | $257K | Buy |
2,991
+507
| +20% | +$43.6K | ﹤0.01% | 2999 |
|
|
2021
Q2 | $277K | Sell |
2,484
-2,614
| -51% | -$291K | ﹤0.01% | 2951 |
|
|
2021
Q1 | $568K | Buy |
5,098
+512
| +11% | +$57K | ﹤0.01% | 2398 |
|
|
2020
Q4 | $487K | Sell |
4,586
-1,041
| -19% | -$111K | ﹤0.01% | 2328 |
|
|
2020
Q3 | $783K | Buy |
5,627
+4,324
| +332% | +$602K | ﹤0.01% | 1801 |
|
|
2020
Q2 | $421K | Buy |
1,303
+441
| +51% | +$142K | ﹤0.01% | 2157 |
|
|
2020
Q1 | $77K | Buy |
+862
| New | +$77K | ﹤0.01% | 2621 |
|
|
2014
Q4 | – | Sell |
-873
| Closed | -$103K | – | 2341 |
|
|
2014
Q3 | $103K | Sell |
873
-323
| -27% | -$38.1K | ﹤0.01% | 2100 |
|
|
2014
Q2 | $155K | Buy |
+1,196
| New | +$155K | ﹤0.01% | 2043 |
|